![Tomasz P. Stryjewski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomasz P.
Stryjewski has founded Helio Vision, Inc. in 2016 and Pykus Therapeutics, Inc. in 2016.
Dr. Stryjewski is the founder and holds the title of Chief Scientific Officer at Pykus Therapeutics, Inc.
| Sociétés | Poste | Début |
|---|---|---|
Pykus Therapeutics, Inc.
 Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops dissolvable intraocular surgical devices | Fondateur | 01/01/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Health Technology |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops dissolvable intraocular surgical devices | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
